Drug Absorption in Geriatric patients and older people
A TRAINING NETWORK INNOVATING DRUG DEVELOPMENT FOR THE ADVANCED AGE POPULATION
The advanced age population (>65 years) is affected by an increase in the number and complexity of illnesses, including that of chronic diseases. Current medical formulation, however, is based on clinical studies of adults aged 18-55 years, meaning that a crucial part of the population in need of medications is not considered during key steps of drug development. The needs of the advanced age population will be addressed by AGePOP, a multidisciplinary training and research programme, bringing together expertise from academia, industry and clinics.
AGePOP is an Innovative Training Network (ITN) that will train 11 Early Stage Researchers (ESR) to better understand the gastrointestinal tract and metabolism of geriatric patients and older people. They will propose modified oral drug formulations for the advanced age population, with increased swallowability, absorption and improved curative effects. The ESRs will be trained as specialised scientists to implement changes in the oral drug product development process, enhancing their career perspectives and employability and contributing to their skill development.
6 Beneficiaries and 8 Partner Organisations from 5 countries work together in the AGePOP project. The collaboration creates the ideal synergy between academic knowledge and mentoring experience, industrial know-how
and innovative technology, and renowned expertise in clinical practice. With their expertise, the partners jointly work towards understanding drug development for the advanced age population from bench to bedside.